We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KA
8176
DELISTED
Kineta, Inc. Common Stock
KA
$3.56K ﹤0.01%
+6,709
New +$3.51K
SLDPW icon
8177
Solid Power Inc Warrant
SLDPW
$8.72M
$3.56K ﹤0.01%
+21,576
New +$4.15K
ICCT
8178
DELISTED
iCoreConnect
ICCT
$3.55K ﹤0.01%
191
+173
+961% +$3.74K
CAML icon
8179
Congress Large Cap Growth ETF
CAML
$378M
$3.55K ﹤0.01%
111
-1,028
-90% -$31.6K
TOUS icon
8180
T. Rowe Price International Equity ETF
TOUS
$1.59B
$3.54K ﹤0.01%
+130
New +$3.57K
QNRX
8181
Quoin Pharmaceuticals
QNRX
$8.94M
$3.54K ﹤0.01%
174
+28
+19% +$711
MDXH icon
8182
MDxHealth
MDXH
$21.5M
$3.51K ﹤0.01%
1,470
-133
-8% -$357
GGUS icon
8183
Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF
GGUS
$440M
$3.51K ﹤0.01%
+71
New +$3.31K
DWSH icon
8184
AdvisorShares Dorsey Wright Short ETF
DWSH
$6.29M
$3.5K ﹤0.01%
466
+425
+1,037% +$3.13K
VEGA icon
8185
AdvisorShares STAR Global Buy-Write ETF
VEGA
$89.8M
$3.48K ﹤0.01%
83
+59
+246% +$2.42K
JETU icon
8186
MAX Airlines 3x Leveraged ETN
JETU
$6.36M
$3.47K ﹤0.01%
168
+97
+137% +$2.04K
OMEX icon
8187
Odyssey Marine Exploration
OMEX
$34.9M
$3.46K ﹤0.01%
710
-179,349
-100% -$770K
QLC icon
8188
FlexShares US Quality Large Cap Index Fund
QLC
$1.02B
$3.44K ﹤0.01%
+56
New +$3.3K
INDH
8189
WisdomTree India Hedged Equity Fund
INDH
$5.94M
$3.43K ﹤0.01%
+80
New +$3.31K
FNUC
8190
Frontier Nuclear and Minerals Inc
FNUC
$40.5M
$3.43K ﹤0.01%
+370
New +$4.17K
ATRA icon
8191
Atara Biotherapeutics
ATRA
$75.5M
$3.43K ﹤0.01%
403
-3,856
-91% -$58K
NVCR icon
8192
PUT
NovoCure
NVCR
$1.73B
$3.43K ﹤0.01%
200
-10,800
-98% -$190K
EZGO
8193
EZGO Technologies
EZGO
$2.09M
$3.42K ﹤0.01%
+1
New +$7.01K
VBNK
8194
VersaBank
VBNK
$623M
$3.41K ﹤0.01%
317
+211
+199% +$2.13K
CRESW
8195
DELISTED
Cresud SACIF y A. Warrant
CRESW
$3.41K ﹤0.01%
6,951
+5,696
+454% +$3.39K
UJUN icon
8196
Innovator US Equity Ultra Buffer ETF June
UJUN
$187M
$3.39K ﹤0.01%
106
-3,133
-97% -$98.2K
ZVIA icon
8197
Zevia
ZVIA
$122M
$3.39K ﹤0.01%
5,021
-24,253
-83% -$22.4K
MNYWW
8198
MoneyHero Ltd Warrants
MNYWW
$3.38K ﹤0.01%
42,832
+42,822
+428,220% +$3.95K
NAII icon
8199
Natural Alternatives International
NAII
$14.4M
$3.38K ﹤0.01%
+562
New +$3.65K
MRIN
8200
DELISTED
Marin Software
MRIN
$3.38K ﹤0.01%
1,457
+1,196
+458% +$2.99K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.